Laurie Toich, Assistant Editor

A new treatment for MS was found effective in animal models.

Nanoparticles can inhibit aggressive breast cancer growth.

Women taking metformin for diabetes were less likely to develop cancer or experience cancer-related death than women not taking the drug.

Top news of the day from across the healthcare landscape.

Researchers consider whether eradicating HCV and HBV is an obtainable goal given the high cost of antiviral drugs.

Medicare Advantage enrollees have lower avoidable hospitalization rates than traditional fee-for-service Medicare patients.

Hearing loss carries significant negative health-related effects.

Previous studies that have linked birth defects and epileptic drugs may not be accurate.

A new antibiotic has been shown to treat severe acne without the adverse side effects of isotretinoin.

Top news of the day from across the healthcare landscape.

Ten tips for successfully working with large employers in regards to value-based care.

Medical androgen deprivation therapies combined with other treatments may cause relapse in patients with prostate cancer.

Current drug interaction software has been shown to be ineffective.

Researchers explore possible options for lowering low-density lipoprotein cholesterol.

Researchers now know what causes such severe side effects from Clozapine.

Top news of the day from across the healthcare landscape.

An algebraic equation may help optimize prescription drug dosing.

People who consume 2.5 servings or more of coffee per day found to have a 50% lesser risk of developing colorectal cancer.

Top news of the day from across the healthcare landscape.

While a large amount of Americans have obesity, an astonishing percent do not take weight loss medication.

The anti-inflammatory drug failed to meet primary endpoints in patients who suffered an acute heart attack.

The experimental drug CMX-2043 protected heart muscle from stenting but it has shown no increased protection in kidneys.

The combination drug Genvoya offers minor benefits in pretreated women and no benefit in pretreated men with HIV.

The combination drug Genvoya offers minor benefits in pretreated women and no benefit in pretreated men with HIV.

With a shift towards digital technology, people will be able to better access and manage their medical records.

Concerns raised regarding a three-fold rise in the cost of insulin as other diabetes drugs remained stable.

Top news of the day from across the healthcare landscape.

Study finds a limit to the benefits of renin-angiotensin system blockers for heart failure.

Excluded drugs and step therapy requirements can create hurdles for patients to access needed treatments.

Heart stabilizing drugs administered after a cardiac arrest may not be as effective as previously thought.